Status:
COMPLETED
Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
VITILIGO
Eligibility:
All Genders
18-65 years
Brief Summary
This study aims to evaluate some differences in the immune system between patients with vitiligo and patients without the disease. These differences will be evaluated by the extraction of peripheral ...
Eligibility Criteria
Inclusion
- \- Patient with vitiligo without treatment
Exclusion
- Patient with inmunosupressive disease
- Patient receiving vitiligo treatment
Key Trial Info
Start Date :
October 27 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 13 2016
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03249064
Start Date
October 27 2015
End Date
September 13 2016
Last Update
August 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain, 08025